Jenburkt Pharmaceuticals standalone net profit rises 31.15% in the September 2024 quarter

Net profit of Jenburkt Pharmaceuticals rose 31.15% to Rs 9.60 crore in the quarter ended September 2024 as against Rs 7.32 crore during the previous quarter ended September 2023. Sales rose 7.65% to Rs 41.22 crore in the quarter ended September 2024 as against Rs 38.29 crore during the previous quarter ended September 2023.

Particulars	Quarter Ended
	Sep. 2024	Sep. 2023	% Var.
Sales	41.22	38.29	8
OPM %	27.73	23.77	-
PBDT	13.16	10.13	30
PBT	12.52	9.54	31
NP	9.60	7.32	31